Malignant involvement of the iliopsoas muscle associated with non‐small cell lung cancer: Two case reports

Key Clinical Message Under the current progression of molecular targeting or immune therapy, early detection and radiation therapy of iliopsoas metastasis will not only improve performance status but also enable the continuation of effective systemic cancer treatment. Clinical course of Case 1.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical Case Reports 2024-01, Vol.12 (1), p.e8368-n/a
Hauptverfasser:	Kodama, Ken, Momozane, Toru, Shigetsu, Kaichi, Takehara, Hiroshi, Toyofuku, Takamasa, Nishiyama, Kinji, Koh, Genju, Uryu, Kiyoaki
Format:	Artikel
Sprache:	eng
Schlagworte:	ALK inhibitors Analgesics Antimitotic agents Antineoplastic agents Back pain Cancer therapies Case reports Case Series Cell death Disease Gene amplification Hospitals Immunotherapy Kinases Ligands Lung cancer Lung cancer, Non-small cell Lymphatic system malignant psoas syndrome (MPS) Metastasis Morphology Narcotics non‐small cell lung cancer (NSCLC) pembrolizumab Pleural effusion Radiation therapy Radiotherapy Surgery Thoracic surgery Tomography
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Key Clinical Message Under the current progression of molecular targeting or immune therapy, early detection and radiation therapy of iliopsoas metastasis will not only improve performance status but also enable the continuation of effective systemic cancer treatment. Clinical course of Case 1.
ISSN:	2050-0904 2050-0904
DOI:	10.1002/ccr3.8368